SymbyAI, an innovative SaaS platform, has raised $2.1 million in seed funding to transform scientific research. Founded by Ashia Livaudais and Michael House, the platform offers a unique AI solution that streamlines the research process, protecting intellectual property while supporting collaboration among researchers.
Trump administration's actions blocking NIH grant approvals lead to uncertainty for researchers focusing on diseases like Lyme, heart, and lung diseases. The delay in publishing grant meeting notices creates hurdles for vital health research funding.
